Eventide Asset Management - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 304 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,513,300
+14.8%
110,0000.0%0.08%
+5.6%
Q1 2023$3,931,400
-5.4%
110,0000.0%0.07%
-12.2%
Q4 2022$4,154,700
-14.6%
110,0000.0%0.08%
-14.6%
Q3 2022$4,865,000
+19.5%
110,0000.0%0.10%
+10.3%
Q2 2022$4,072,000110,0000.09%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders